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The X-ray structure of an immunoglobulin light-chain dimer
isolated from the urine as a `Bence-Jones protein' from a
patient with multiple myeloma and amyloidosis (Sea) was
determined at 1.94 AÊ resolution and re®ned to R and Rfree
factors of 0.22 and 0.25, respectively. This `amyloidogenic'
protein crystallized in the orthorhombic P212121 space group
with unit-cell parameters a = 48.28, b = 83.32, c = 112.59 AÊ as
determined at 100 K. In the vital organs (heart and kidneys),
the equivalent of the urinary protein produced ®brillar
amyloid deposits which were fatal to the patient. Compared
with the amyloidogenic Mcg light-chain dimer, the Sea protein
was highly soluble in aqueous solutions and only crystallized
at concentrations approaching 100 mg mlÿ1. Both the Sea and
Mcg proteins packed into crystals in highly ordered arrange-
ments typical of strongly diffracting crystals of immuno-
globulin fragments. Overall similarities and signi®cant
differences in the three-dimensional structures and crystalline
properties are discussed for the Sea and Mcg Bence-Jones
proteins, which together provide a generalized model of
abnormalities present in  chains, facilitating a better under-
standing of amyloidosis of light-chain origin (AL).
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1. Introduction
Amyloidosis of immunoglobulin light-chain origin (AL)
belongs to a group of diseases known as plasma-cell dyscrasias
(Falk et al., 1997; Stone, 1990). AL can be found in the
presence or absence of multiple myeloma, which is char-
acterized by multiple tumors of the bone marrow. Fibrils of
amyloid are composed of intact or fragmented monoclonal
light chains synthesized by plasma cells, which are commonly
found in increased numbers in the bone marrow of patients
with AL or multiple myeloma (Buxbaum et al., 1990). While
treatment for AL has been unsatisfactory in the past, attempts
have been made to use alkylating agents or other medicinals
known to be effective in reducing plasma-cell proliferation
like that found in multiple myeloma (Kyle et al., 1997; Pascali,
1995). New approaches being developed for the treatment of
AL include the use of humanized antibodies directed against
the causative light chains (Alan Solomon, personal commu-
nication).
In approximately 10% of subjects with multiple myeloma,
the light chains (L-chains) exit the blood stream and precipi-
tate as pathological amyloid deposits in vital organs such as
the kidney, heart, tongue and skin (Glenner, 1980; Glenner et
al., 1971; Kyle & Gertz, 1995; Osserman et al., 1964; Solomon
& Weiss, 1995). Clinical diagnosis typically begins with
nephropathy accompanied by Bence-Jones proteinuria. While
the latter can be asymptomatic in the early stages, the disease
research papers
816 Bourne et al.  Immunoglobulin light-chain dimer Acta Cryst. (2002). D58, 815±823
progresses through a nephrotic syndrome to renal failure.
Preferential deposition of AL ®brils in the heart myocardium
tends to be dominant, but often remains uncon®rmed until
autopsy. For more de®nitive diagnoses, clinical ®ndings may be
supplemented by histochemical, electrophoretic, antigenic and
amino-acid sequence analyses of the amyloid-in®ltrated
tissues. One of the most common staining procedures utilizes
Congo red to produce a green birefringence under polarizing
light. Alternatively, electron microscopy may be employed to
scan the tissues for diagnostic amyloid ®brils. Morphologically,
®brillar deposits of AL are indistinguishable from amyloid
®brils produced by other precursors in at least 18 diseases
(Wall et al., 1999), including diabetes and Alzheimer's disease.
These deposits are characterized by unbranched ®brils 80±
110 AÊ in diameter (Glenner et al., 1971). Fiber-diffraction
methods demonstrated that the principal underlying struc-
tures of AL ®brils were -pleated sheets, in which the direc-
tions of the -strands were perpendicular to the long axes of
the ®brils (Glenner, 1980; Sunde & Blake, 1997).
For the studies described in the present article, Bruce D.
Cheson MD, an oncologist at the University of Utah Medical
Center, identi®ed a patient (Sea) with multiple myeloma and
amyloidosis associated with a -type immunoglobulin L-chain.
We con®rmed his diagnosis by showing that the Sea Bence-
Jones dimer, together with two other amyloidogenic -chains
(Mcg and Bla) and one  chain (Jen), formed amyloid ®brillar
deposits in ®broblast monolayer cell cultures (Harris et al.,
2000). These deposits gave a green birefringence when stained
with Congo red. After 48 h, ®ne ®laments were found to be
interspersed with nascent collagen (types I and III) synthe-
sized by the ®broblasts. By 72 h, the ®ne ®laments had
developed into dense amyloid ®brils.
Amyloid ®brillogenesis was observed to impede the
maturation of collagen, as evidenced by the absence of char-
acteristic black-and-white banding patterns in electron
micrographs. Using ¯uroescein- and gold-labelled anti-
L-chain antibodies, the amyloidogenic L-chains were observed
to decorate the surfaces of the nascent collagen strands. After
72 h, amyloid ®brils were wedged into bundles of nascent
collagen, causing the latter to disintegrate. As a control, we
selected a -type Bence-Jones protein from a myeloma patient
(Hud) who showed no symptoms or signs of AL amyloidosis.
In electron micrographs of ®broblast monolayers bathed with
the Hud protein, we were not able to detect amyloid ®brils.
Collagen produced by the ®broblasts passed smoothly through
nascent stages to the fully developed cross-linked ®bers with
alternating black-and-white banding patterns.
These results strongly suggested that the amyloidogenic
L-chains were attracted to and trapped in perivascular tissues
by antigen±antibody-like reactions. Such an assumption was
supported by previous crystallographic studies of complexes
of the prototypic amyloidogenic dimer from Mcg with more
than 80 small organic molecules and peptides (Edmundson et
al., 1975, 1984, 1987, 1993; Edmundson & Ely, 1985; Herron et
al., 1985). Each of these ligands was bound in the designated
active site and in no other location. After our demonstration
that the Mcg dimer showed binding activity for dinitrophenyl
compounds, Osserman's group found that similar haptens
bound to seven other Bence-Jones proteins from subjects with
documented amyloidosis but not to six L-chains derived from
myeloma patients without AL (Bertram et al., 1980).
In other studies related to the present work, we tried to
develop model systems covering both the Sea and Mcg
proteins. However, preliminary results with the Mcg dimer
were too destructive to be extended to Sea. When collagen-
like synthetic polymers such as (Gly-Pro-Pro)5 and (Gly-
hydroxy-Pro-Pro)s were diffused into pre-existing Mcg crys-
tals, widespread structural alterations were detected in both
the VL and CL domains by difference Fourier analysis. On a
positive note, these structural alterations could be completely
prevented by pre-treatment of the crystals with blocking
agents speci®c for the Mcg active site (e.g. the collagenase
substrate PZ-Pro-Leu-Gly-Pro-d-Arg, where PZ is a
4-phenylazobenzyloxycarbonyl moiety; WuÈ nsch & Heidrich,
1963).
2. Experimental
2.1. Purification and crystallization of the Sea Bence-Jones
dimer
The Sea Bence-Jones protein was isolated and puri®ed by
methods described previously (Alvarado et al., 2001). Final
steps in puri®cation were based on gel ®ltration over Sephacyl
S-200 and ion-exchange chromatography on DEAE-cellulose.
The DEAE step was essential to remove a yellow urinary
pigment from the samples of Bence-Jones protein isolated by
precipitation from the urine with 2 M ammonium sulfate.
Unusually in relation to other light chains, Fv and Fab samples
in our collection, the Sea dimer was inordinately soluble in
aqueous and PEG solutions. Therefore, extreme conditions
were necessary for producing large crystals suitable for X-ray
analysis with conventional in-house equipment. Several
methods of crystallization were used with different degrees of
success, all with polyethylene glycol (PEG 8000) at tempera-
tures ranging from 277 to 295 K. Finally, a new method was
introduced to promote crystallization of the Sea dimer
(Alvarado et al., 2001). To stimulate nucleation, a sample
dissolved in PEG 8000 in a glass capillary was subjected to
rapid dehydration through vapor diffusion of water across an
air gap into a strong absorbent (100% glycerol) for a relatively
short duration (12 h). The absorbent was then weakened to
80% glycerol for slower growth of the crystals over a longer
period (at least 13 d). Initial protein concentrations were
required to be greater than twice those required for crystal-
lization of other more typical L-chains. Dehydration tech-
niques drove the effective concentrations toward values of
100 mg mlÿ1.
Crystals prepared by these methods belong to space group
P212121, with unit-cell parameters a = 48.99, b = 85.15,
c = 113.89 AÊ ,  =  =  = 90 (as determined at ambient
temperature). The crystals diffracted to high resolution but
were sensitive to radiation damage from the X-ray beam.
Unless they were more than 0.3 mm in thickness, they
dissolved in about 20 h at ambient temperatures in an X-ray
beam generated by a rotating anode operating at 50 kV and
90 mA. However, larger crystals decayed slowly enough to
yield diffraction data that were 98% complete in 36 h. These
problems were circumvented by ¯ash-freezing of the crystals
and collection of X-ray diffraction data at 100 K.
2.2. Collection of X-ray diffraction data
X-ray diffraction data were collected at ambient tempera-
tures at the Photon Factory, Tsukuba, Japan. Although suf®-
cient to determine an initial structure for the Sea dimer,
radiation damage to the crystal resulted in an incomplete data
set (46% overall). It was therefore necessary to collect data of
higher quality. Diffraction data were collected at 100 K using a
Rigaku RUH3R rotating-anode generator with an R-AXIS IV
image-plate detector. For these studies, the crystals were
transferred to a cryoprotectant solution of 8% PEG 8000 and
28% PEG 400. At 100 K, the unit cell was found to have
contracted to a = 48.28, b = 83.32, c = 112.59 AÊ . All data
collected on the R-AXIS IV image plate were reduced and
scaled using the programs DENZO and SCALEPACK
(Otwinowski & Minor, 1997). Statistics for these data are
presented in Table 1.
2.3. Determination of the amino-acid sequence of the Sea
k-chain
As in many -chains (Kabat et al., 1991), the N-terminal
residue was cyclized to pyrrolidone carboxylic acid (PCA or
pyroglutamate). After removal of the blocked end group with
pyroglutamyl aminopeptidase, the ®rst 40 residues were
identi®ed by repetitive Edman degradation with an automated
sequencer. Ambiguities in the sequence of the last part of this
segment were resolved by detailed exam-
inations of soluble peptides obtained by
proteolytic digestion with trypsin. Other
peptides in the tryptic series covered the
remainder of the VL (variable domain of
the L-chain). In checking the sequence
against electron-density maps of the Sea
dimer, we found no discrepancies between
the chemical and crystallographic residue
assignments.
2.4. Determination of the three-
dimensional structure of the Sea dimer
The crystal structure was solved by the
molecular-replacement method (Fitzgerald,
1988; Rossmann, 1990), using the preli-
minary synchrotron X-ray diffraction data.
Rotation-function calculations (Crowther,
1972; Crowther & Blow, 1967) were initially
performed with the MERLOT program
package (Fitzgerald, 1988), with X-ray
diffraction data in the resolution range 15±
4.0 AÊ . The complete Mcg dimer was used as
a starting model, but since this procedure
did not produce a clear-cut solution, the starting model was
changed to a heterologous L-chain dimer engineered from
Mcg and Hud monomers (Allen Edmundson et al., unpub-
lished work). Disul®de-linked heterologous dimers can be
produced if one monomer (e.g. McgÐSÐ) is reduced and the
second is converted to a mixed disul®de (e.g. HudÐSÐSÐ
pyridine). This treatment (Peabody et al., 1980; Shaw et al.,
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Table 1
Summary of data collection at 100 K and statistics for the model
re®nement.
Values in parentheses are for the outer resolution shell.
Sea model
Resolution range (AÊ ) 30.0±1.94 (2.01±1.94)
Completeness 98.2 (89.1)
Rsym² 0.043 (0.319)
hIi/h(I)i 29.6 (3.78)
Redundancy 4
Unique re¯ections 33848
Final Rcryst³ (%) 22.3
Rfree (5% total data) (%) 25.4
No. of protein residues 429
Average B factor (protein) (AÊ 2) 34.65
No. of water molecules 264
Average B factor (solvent) (AÊ 2) 39.18
R.m.s. deviations from ideality
Bond lengths (AÊ ) 0.01
Bond angle () 1.73
R.m.s. deviations from ideality in B factors (AÊ 2)
(values in parentheses are for the target)
Main-chain bonds 1.684 (1.5)
Main-chain angles 2.739 (2.0)
Side-chain bonds 2.317 (2.0)
Side-chain angles 3.299 (2.5)
² Rsym =
P
h
P
J jhIhi ÿ IJhj=
P
h
P
J Ih, where I(h) is the intensity of re¯ection h.
P
h
is the sum over all re¯ections and
P
J is the sum over J measurements of the
re¯ection. ³ Rcryst =
PjFoj ÿ jFcj=P jFoj.
Figure 1
An example of electron density from the ®nal 2Foÿ Fc map contoured at 2(). The ®gure was
generated with the program BOBSCRIPT (Esnouf, 1997). The selected segment belongs to
FR3 and immediately precedes the second inter-chain Cys residue and CDR3 of monomer B.
research papers
818 Bourne et al.  Immunoglobulin light-chain dimer Acta Cryst. (2002). D58, 815±823
1987) ameliorates the overwhelming preference for self-
dimerization, rather than similar interactions with hetero-
logous light chains (Stevenson & Straus, 1968). The three-
dimensional structure of the Mcg  Hud hybrid has been
determined to 1.8 AÊ resolution and is being prepared for
publication.
The elbow bend angle of this hybrid dimer was increased
stepwise from the initial value of 113 by 40 in 10 intervals
and each modi®ed structure was examined by the molecular-
replacement method. An elbow bend is de®ned as the angle
subtended by the pseudodyad between the VL1 and VL2
domains and the pseudo-twofold axis between CL1 and CL2.
A single peak was obtained when the elbow bend angle was
expanded by 20. Results obtained with other modi®cations of
the starting probe were less convincing. When the diffraction
data collected at 100 K became available, the preliminary
model was re®ned against these data using the CNS suite of
programs (BruÈ nger et al., 1998) and REFMAC5 (Murshudov et
al., 1999). The same set of re¯ections was used to calculate
Rfree (BruÈ nger, 1992) for re®nement with CNS and
REFMAC5. The current R factor is 0.22 for all data in the
resolution range 30±1.94 AÊ . From 5% of randomly distributed
re¯ections, Rfree was calculated to be 0.25 (see Table 1). In the
Ramachandran plot, as de®ned with the program
PROCHECK (Laskowski et al., 1993), 88.2% of the non-
glycine residues were located in the most favored regions. An
example of the ®nal 2Fo ÿ Fc electron density is presented in
Fig. 1. Final model coordinates have been deposited in the
PDB (Berman et al., 2000).
3. Results and discussion
3.1. Amino-acid sequence of the Sea protein
The amino-acid sequence of the Sea -chain is presented in
Fig. 2, which also includes the Mcg sequence for comparison.
The Mcg immunoglobulin was originally classi®ed as subgroup
V of -chains (Kabat & Wu, 1991). After extensive additions
to the sequence database, both Mcg and Sea proteins are now
considered to belong to subgroup II (Alan Solomon, personal
communication). Each Sea monomer was longer than the
Mcg -chain by one amino-acid residue. This difference was
localized to the CDR3 segment, which contains an extra serine
residue in Sea [a product of the joining (J) gene]. Overall,
there were 23 substitutions in the Sea VL sequence relative to
that in the Mcg protein.
3.2. Solubility differences between the Sea and Mcg dimers
The Sea dimer is considerably more soluble than the Mcg
protein in aqueous solutions. For example, the Mcg dimer has
euglobulin properties and the Sea dimer does not. It seems
likely that these differences are attributable to the VL
domains, since the C domains have only four sequence inter-
changes. In the Sea dimer there are 12 more VL serines
located in surface positions accessible to solvent. Overall
counts of polar and hydrophobic side chains are otherwise
quite similar in the two dimers. GRASP plots (Nicholls et al.,
1991) and hydrophilicity plots do not reveal features clearly
related to the disparities in solubility.
However, solubility differences were manifested in the
crystallization trials for the two proteins. For instance, crys-
tallization of the Sea dimer was dif®cult to achieve until the
®nal protein concentration approached 90±100 mg mlÿ1
immediately before nucleation and crystal growth. When
urinary samples containing 4 mg mlÿ1 of Mcg Bence-Jones
protein were dialyzed against deionized water for 12 h at
277 K, approximately 50% of the protein crystallized as long
thin plates and the other half remained in solution. With
highly puri®ed samples of the Mcg dimer, diffraction-quality
crystals could be produced in capillaries by slow dialysis
against deionized water at ambient temperature (Abola et al.,
1980; Ely et al., 1989).
3.3. Comparison of the general features of the Sea and Mcg
dimers
As mentioned earlier, the Sea dimer crystallized in PEG
8000 in the orthorhombic space group P212121, with the
asymmetric unit consisting of a dimer with a total of 434
amino-acid residues. In ammonium sulfate the Mcg dimer
formed crystals with the trigonal space group P3121 and unit-
cell parameters a = b = 72.3, c = 185.9 AÊ ,  =  = 90,  = 120;
the asymmetric unit was a dimer with 432 residues. Unit-cell
volumes were 475 092 AÊ 3 for the Sea crystals (analysed at
ambient temperature) and 838 420 AÊ 3 for the Mcg crystals.
There were four asymmetric units in the Sea unit cell and six in
the Mcg cell. By Matthews' procedure (Matthews, 1968), the
Figure 2
Amino-acid sequences of the VL domains of the Sea and Mcg -type
Bence-Jones dimers. The three hypervariable loops are labeled CDR1,
CDR2 and CDR3. One-letter codes for the amino-acid residues are
numbered according to the system of Kabat et al. (1991). A gap is left at
position 10, which corresponds to a deletion in the -chain sequences.
Insertions in the Sea and Mcg sequences but not in all light chains are
designated 27a, 27b, 27c and 95a. An extra serine residue is found in
position 95b of Sea, but is absent in the Mcg sequence. Note that there are
only eight differences in the 32 positions of the three CDRs. The two
molecules belong to the same VL subgroup (II) and both act as
precursors in lethal amyloid ®brillogenesis. In other ®gures, please note
that the PDB format is followed for numbering residues without gaps or
insertions in the sequence. Figs. 1, 6 and 7 in particular deviate slightly
from the Kabat numbering system.
partial solvent volumes (Vsolv) in the Sea and Mcg unit cells
were estimated to be 47.8 and 56.0%, respectively.
We have emphasized that the Sea dimer differs in shape,
solubility and physical characteristics from the Mcg protein.
Rotation angles relating VL1 and VL2, and CL1 and CL2
were calculated to be very close to exact dyads (179.6) in the
Sea protein. Measurements of the elbow bend angles between
the pseudodyads of the VL and CL pairs of domains were
based on comparisons of residues (38 from VL and 34 from
CL) from the most ordered portions of the -pleated sheets
(Edmundson et al., 1975). The elbow bend angles were 133.6
in the Sea dimer and 113.0 in the Mcg dimer. This difference
helps to explain why the determination of the Sea structure
was facilitated by an increase of 20 in the elbow bend of the
Mcg  Hud heterologous dimer used as the starting model.
Dissecting the models more thoroughly, we found that both
L- and H-chain analogs in the Sea protein were more extended
than in the Mcg molecule. For instance, the angles between VL
and CL in the L-chain analogs were 118.1 in Sea and 110.5 in
Mcg, while the corresponding angles in the H-chain analogs
were 70.8 (Sea) and 43.5 (Mcg). Such large differences in the
segmental ¯exibility of domains were re¯ected in the crossing
angles between the VL1 and VL2 and the CL1 and CL2
domains in the Fab-like dimers. For example, the VL1 and
VL2 domains crossed each other at an angle of 73.8 in the Sea
dimer and 96.4 in the Mcg dimer. Relationships between CL1
and CL2 were more similar in the two proteins: the crossover
angles were 88.3 in Sea and 91.0 in
Mcg.
3.4. Comparison of CDR1 and CDR3 in
the Sea and Mcg dimers
Ribbon models for the Sea and Mcg
dimers are shown in Fig. 3. Examinations
of these three-dimensional structures
reveal differences that are also impor-
tant in determining the solubility of each
molecule. Despite having the same
number of residues as Mcg, the CDR1
loops of the Sea dimer protrude into
bulk solvent to a signi®cantly greater
extent (see Fig. 4). Moreover, the Sea
dimer is more extended than the Mcg
protein, as evidenced by the observation
that the elbow bend angle in the Sea
dimer is 20 greater. Practical conse-
quences are greater exposures of
segments in the interface between the V
and C domains and particularly more
accessibility of the surface residues of
the CL domain of monomer B.
While not directly expanding the
crown of the CDR3 loop, the insertion of
the extra serine residue in Sea affected
not only the size but also the shape of
this hypervariable region. Relative to the
Mcg dimer, the CDR3 loops in the two
conformational isomers of the Sea protein were much more
convoluted, especially at the top (see Fig. 5). Conformational
differences between the CDR3s in the two Sea monomers are
also worthy of comment. Although the electron density for the
LCDR3 of monomer A was relatively weak, it was suf®cient to
discern these obvious differences in main-chain conforma-
tions. In the light-chain analog (Sea monomer A), the CDR3
loop was contorted at its crest. Its vertical position was lower
than that of the adjacent CDR1. In contrast, CDR3 in the
heavy-chain analog (monomer B) was longer and thinner and
was situated in a position above that of CDR1. At the base, the
two CDR3s were superimposable for the ®rst three residues of
the ascending segment and the last three residues of the
descending arm.
CDR1 of monomer A cannot maintain the same confor-
mation as in monomer B owing to steric restraints imposed by
the packing of the molecules in the crystal lattice. Residues
Ser13A and Pro14A in a symmetry-related molecule occupy
the position that would otherwise be allocated to Ser27A.
Superposition of the framework regions of monomers A and B
show that chain A is distorted from residues 25A to 34A. The
repositioning of CDR1 has the knock-on effect of distorting
CDR3. Tyr93A, usually an important ligand-contact residue, is
pushed aside by Ile28A. These concerted changes in the
orientations of CDRs 1 and 3 in monomer A probably explain
the results of attempts to co-crystallize the Sea dimer with the
methyl ester of Asp-Phe (aspartame), which binds to the
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Figure 3
Comparison of the Sea and Mcg Bence-Jones dimers. The models and stereo diagrams were
constructed with the program MOLSCRIPT (Kraulis, 1991). Each dimer mimics an Fab in
appearance. Yellow tubular segments represent the isomer more nearly approximating the
conformation of the light-chain component of an Fab; steel blue tubes correspond to the heavy-
chain analogs. Pairs of variable domains (V) are on the right and constant domain pairs (C) are on
the left. Strands of -pleated sheets are shown as directional arrows, with the four-stranded layers
colored blue and red in the L- and H-chain conformational isomers. Helices (some distorted) are
depicted as red and yellow spirals. CDRs are numbered 1, 2 and 3. Note that the Sea dimer is more
extended than the Mcg dimer (elbow bend angle of 133 versus 113 for Mcg) and the -pleated
sheets are more regular.
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protein with moderately high af®nity (Kd =
10ÿ7 M) in solution (C. R. DeWitt and A. B.
Edmundson, unpublished data). Under
conditions in which the ligand:protein molar
ratio was kept at 10:1 in the PEG 8000
crystallizing medium, the crystals which
emerged were identical in appearance to
those in the unliganded protein. Difference
Fourier analysis of this crystal form indi-
cated that the peptide ligand was not
present in the active site in the Sea dimer.
We concluded that the conformational
distortions of CDRs 1A and 3A required for
crystallogenesis in this particular habit were
only possible in Sea protein molecules
devoid of bound ligand.
Interactions between CDR3 and CDR1
were different in the two monomers, as
expected from their dissimilar shapes and
relative orientations. In monomer B, the
ladder of hydrogen bonds between the
descending arm of CDR1 and the ascending
arm of CDR3 retained the classical rela-
tionship of two adjacent antiparallel
-strands in a pleated sheet. Both of these
-strands were members of a ®ve-stranded
-pleated sheet. As a guide to the align-
ment, dual hydrogen bonds were formed
between the NH and CO groups of the
polypeptide backbone at Ser36 of CDR1
with the CO and NH groups of Ser91 of
CDR3. The third hydrogen bond was made
between the CO of Leu34 and the NH of
Tyr93. Near the crests of the two loops, a
hydrogen bond was formed between the CO
of Val29 and the NH of Gly95 only in
monomer B. This hydrogen bond was the
key to the close positioning of the two loops.
Because of the relative differences in size
and shape of the two CDRs in monomer A,
the ladder of inter-strand hydrogen bonds
was limited to the ®rst two residues of
CDR1. These differences are clearly evident
in Fig. 6.
3.5. Packing interactions of the Sea dimer
Prominent packing interactions involve
the ®rst three residues of the monomer A
VL domain. Interactions of monomer A fall
under the precepts of our triad hypothesis
(Edmundson et al., 1998, 1999) for the
formation of extended -pleated sheets by
pairing of antiparallel -strands from
symmetry-related dimers across twofold
axes in the crystal lattice. Unlike other
examples of such packing, the outermost
Figure 5
Comparison of the CDR3s of the Sea and Mcg Bence-Jones dimers, presented as stereo
diagrams. Components of monomer B (H-chain analogs) are colored magenta and segments of
monomer A (L chains) are yellow. CDR3 loops act as pillars of the active sites and their relative
locations in each dimer largely determine the magnitudes of the openings into the binding
cavities. This opening is signi®cantly narrower in the Sea dimer (8 versus 15 AÊ ), but the depths
are practically the same. The phenylalanine residues at the lower ends mark the ¯oors of the
cavities. This ®gure was prepared with the program MOLSCRIPT (Kraulis, 1991).
Figure 4
Stereo diagrams showing the comparison of the V domain pairs from the Sea and Mcg Bence-
Jones dimers. `Framework' regions (FRs) are shown in magenta for the L-type isomers
(monomer A) and are labeled VL. H-chain analogs (monomer B) have cyan-colored FRs and
are marked VH. All CDR1 loops are colored green, CDR2s yellow and CDR3s red. Note the
differences in spatial relationships of CDR1 and CDR3 loops in the Sea dimer with respect to
those in Mcg. The Sea pair is more upright and the CDR1 loops protrude farther out into the
bulk solvent. This ®gure was generated with the program MOLSCRIPT (Kraulis, 1991).
segment (designated 4-1) of the reference VL domain is
paired with the second -strand (numbered 4-2) of an anti-
parallel pleated sheet in a symmetry-related molecule. The
carbonyl O atom of the pyrrolidone carboxylic acid (PCA) in
position 1 of the reference molecule is hydrogen bonded to the
NH group of Thr19 in -strand 4-2 of monomer A in an
adjacent Sea dimer. The NH and terminal O atom of PCA 1
also form hydrogen bonds with the CO of Thr19. Hydrogen
bonds 4 and 5 are formed by interactions of the NH and CO
groups of Ala3 with the CO and NH groups of Ser17. In the
other direction, Ser17 and Thr19 of the reference molecule
hydrogen bond with PCA1 and Ala3 of a third dimer. The
binding pattern is repeated throughout the crystal to produce
ribbons of Sea dimers of inde®nite length (see Fig. 7).
This type of packing arrangement was only possible using
monomer A, as VL segments 4-1 and 4-2 in monomer B are
not in the appropriate orientations after formation of the AB
VL dimer. In the original formulation of the triad hypothesis,
at least four hydrogen bonds were expected to be contributed
by three pairs of residues. Therefore, while elegant, the
stacking pattern of backbone atoms alone falls short of the
stabilization required in the Sea crystal lattice. Two additional
hydrogen bonds (6 and 7) involving side chains compensate
for these de®ciencies. A sixth interaction occurs between the
hydroxyl group of Thr2 in the reference molecule and the
main-chain amide group of Gly15 in the second dimer. Finally,
a seventh hydrogen bond links the hydroxyl groups of Thr5
and Ser17.
3.6. Description of the b-pleated sheets
In the Sea monomers the -pleated sheets are generally
more ordered with respect to their hydrogen-bonding patterns
than they are in the Mcg dimer. This ®nding partly arises from
the lack of crowding at the junction of the
VL and CL domains in monomer B of the
Sea dimer. In Mcg, the acute bend between
these domains tends to disrupt regular
structures on both sides of the bend (see
next paragraph). Sea VL domains in
monomer A and monomer B have an
obvious four-stranded layer that is actually
partitioned into three strands of antiparallel
-pleated sheet and a fourth outer -strand.
The latter is stabilized mainly by parallel
hydrogen bonding with the most lateral -
strand of the second pleated sheet in the
sandwich structure of the VL domain. As in
Mcg, this second -pleated sheet does not
strictly conform to ®ve antiparallel strands,
because the two pillars supporting the
CDR2 loop are not suf®ciently ordered to
classify them as complete -strands.
However, the ascending pillar for CDR2
does have a short segment of -structure,
which interlocks with the other -strands at
the outer edge of the sheet. The connecting
segment between CDR3 with the CL
domain has two segments of -structure
separated by a `-bulge' corresponding to a
Phe-Gly-Gly-Gly sequence in the ®rst part
of VL framework 4 (see residues 98±101 in
Fig. 2). These arrangements of -strands
within the VL and CL domains of mono-
mers A and B are shown as stereo diagrams
in Fig. 3 for both the Sea and Mcg dimers.
In the Sea C domains of both monomers
A and B, the four-stranded -pleated sheets
are again more regular than in the Mcg
dimer. The irregularity in Mcg monomer B
is propagated in the forward direction to VL
and distally into CL by spatial congestion of
chain segments at the interface of VL and
CL. An increase in the VL±CL angle of 28
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Figure 6
Stereo diagrams of the CDR1 and CDR3 loops in the two conformational isomers of the Sea
dimer. CDR1 is yellow in monomer A (L-type isomer) and blue in monomer B (H-chain
analog). CDR3 is magenta in monomer A and red in monomer B. Hydrogen bonds between
CDR1 and CDR3 are designated by dotted lines and the interatomic distances in AÊ between
backbone carbonyl and amide groups are superimposed. Short stretches of antiparallel
-strand pairing occur between the descending arm of the CDR1 loop and the ascending arm of
CDR3 in both monomers. Otherwise, the conformations of the CDR1 and CDR3 loops are
substantially different in the two isomers. The models were drawn with the program
MOLSCRIPT (Kraulis, 1991).
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in monomer B of the Sea dimer allowed components of the
four-stranded layer to assume more relaxed conformations
similar to those in monomer A [the ®rst segment (4-1) of the
four-stranded layer is directly connected to the VL domain].
In both Sea monomers, segment 4-1 is divided into two -
strands by a -bulge consisting of 3±4 residues. Three-stranded
layers in both A and B CL domains are also extremely regular
in the Sea dimer (see Fig. 3).
3.7. Malleable regions which may predispose VL domains to
become amyloidogenic
While the `twisted -pleated sheet conformation' attributed
to amyloid ®brils (Glenner, 1980) is built into the structures of
all L-chains, the subjects with amyloidogenic properties are
generally believed to have regions of instability which
predispose them to AL ®brillogenesis (Alim et al., 1999;
Pokkuluri et al., 1999). Among human -chains, some
subgroups are particularly susceptible to AL formation. For
example, myeloma-derived -chains of subgroup I were found
to have a high propensity for producing amyloid-like ®brils in
vitro after hydrolysis with pepsin (Linke et al., 1973). In
comparative studies (Alim et al., 1999), `Vlambda II' mole-
cules were proposed to have conserved Ser, Thr and Val
residues in positions equivalent to 27, 65 and 93 in Fig. 2. Many
examples of molecules from subgroup I and II, including Sea
and Mcg, have Ser27 in their CDR1 sequences. This is the key
residue at the point of impact in the collision of monomer A of
the Sea protein with a symmetry-related
molecule. In Mcg, the part of CDR1 begin-
ning with Ser27 is almost completely disor-
dered in monomer 1, while the same
sequence in monomer 2 adopts a well
de®ned helical conformation (Edmundson et
al., 1975). These regions are particularly
vulnerable because they constitute major
crossover segments between the two
-pleated sheets of the VL domain structure.
They tend to act as solvent-accessible and
expandable (or contractable) springs that
respond to local or global movements of the
-pleated sheets.
Members of the Vlambda VI subgroup
also display an accentuated tendency for
amyloid formation. Their sequences have
insertions of two residues between residues
68 and 69, which extend a loop adjacent to
CDR1. In a crystallographic comparison of
two molecules of this subgroup (Pokkuluri et
al., 1999), one (Wil) was susceptible to
amyloidosis and the other (Jto) participated
in ionic and hydrophobic interactions that
promoted stability and thereby interfered
with ®brillogenesis.
Conveniently for the present discussion,
an X-ray analysis in our laboratory is
nearing completion for the Mcg  Hud
heterodimer. By itself, the Hud -chain
dimer was obtained from a patient with
documented multiple myeloma but no
evident ®brillar deposits (Alan Solomon,
personal communication). Preliminary
examinations of electron-density maps of
the Mcg  Hud hybrid indicate no CDR1
instability of the types seen in the Sea and
Mcg dimers. An explanation for these
observations is now obvious. In the Hud L-
chain, proline is substituted for serine in
position 27 of the Sea and Mcg proteins and
thus renders CR1 much more rigid. Pro15 is
retained as in the `battering-ram' turn of the
Figure 7
(a) Stereo diagram of major packing interactions in the Sea crystal lattice. Two symmetry-
related molecules of the Sea dimer are colored magenta (reference molecule) and yellow. A
copy of the yellow molecule translated by one unit-cell dimension is colored blue. Arrows
designate the -strands that are paired to form the principal interactions in the nucleation and
growth of the crystal. On the left, the magenta arrow designates the -strand which contains
Thr17 and Ser19 of monomer A. This strand makes a cross-molecule antiparallel -pleated
sheet with residues 1±5 of monomer A in the yellow dimer. On the right, the magenta arrow
covers residues 1±5 (monomer A) which forms an antiparallel sheet with the -strand, which
includes residues 17±19 in the blue dimer. Such bilateral -strand pairing interactions continue
until they collectively produce a ribbon of molecules of inde®nite length in the crystal lattice.
(b) Stereo representation of the hydrogen bonding in the intermolecular antiparallel -sheet
described above. This ®gure was produced with the program MOLSCRIPT (Kraulis, 1991)
Sea protein. Alanine is substituted for Ser14 in Sea, with little
consequence in the three-dimensional structure. Mcg has a
Ser-Leu sequence in positions 14 and 15.
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